The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/85321
Recipharm AB Jordbro, Sweden www.recipharm.com 46 8 602 52 00 DRUG TYPE: Pharmaceuticals Manufacturing locations: France, Germany, Spain, Sweden, and United Kingdom Contact: Mark Quick info@recipharm.com DRUG LIFE CYCLE STAGES: Formulated Drug Production – dosage form development, dosage form production, and packaging SERVICES OFFERED: Aseptic fill/finish, capsules, cartridges, controlled substances, creams & ointments, cytotoxic & high-potency compounds, gels, generics, injectables, liquids, lyophilized products, non-sterile, OTC, parenterals (large volume), parenterals (small volume), powders (non- sterile), semisolids, solid dose, solutions & suspensions, sterile, and topicals. "I am very honoured that Recipharm has won this innovation award. We adopt a partnering approach to customer relations, consequently delivering bespoke services that deliver real value to each customer. Whether this is managing their supply chains and inventory, devising novel technical solutions or taking a share in the risk in product development, Recipharm offers a comprehensive, end-to-end solution. We constantly strive to find ways to enhance the scope and services we offer." — Thomas Eldered, CEO RohnerChem Pratteln, Switzerland www.rohnerchem.ch 41 61 825 1111 DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production SERVICES OFFERED: Controlled substances, liquids, non-sterile, polymers, and powders (non- sterile). DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production SERVICES OFFERED: Cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, non-sterile, ophthalmics, parenterals (large volume), parenterals (small volume), powders (non-sterile), powders (sterile), proteins, solutions & suspensions, sterile, and vaccines. "RohnerChem is very proud to be rated so positively by our valued custom- ers. We are a Swiss based, highly reliable and flexible CMO organization. We pay tremendous attention to project management as well as rapid and open communication with our customers. We can rapidly develop a process and scale up to commercial level. This efficiency has also been rewarded with the "Syngenta Supplier award for innovation 2012" and earlier with "The European Outsourcing Award" together with Solvias." — Dr. Thomas Rosatzin, CEO 46 The CMO Leadership Awards 2012 "As a CMO, SAFC aims to be the supplier of choice in the market. Reliability, innovation, productivity, and regulatory are more than words to our customers. We try to keep that fact in mind at all times and comple- ment that approach with a comprehensive solutions offering. This kind of customer recognition is a true testament to the quality of that solution working in perfect harmony with the fantastic team we have here at SAFC." — Deborah Slagle, vice president of marketing and R&D; Manufacturing location: Pratteln, Switzerland Contact: Dr. Andreas Meudt andreas.meudt@rohnerchem.ch DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – discovery and pre-clinical Drug Substance Production – primary process development and drug substance production SERVICES OFFERED: Proteins, semisolids, soft gels, syringes (pre-filled), topicals, vaccines, and others. Roche Custom Biotech Indianapolis, IN www.roche-applied-science.com/ custom-biotech (800) 428-5433, ext. 14649 Manufacturing locations: Branchburg, NJ, and Penzberg, Germany Contact: Pat Sankhavaram custombiotech.ussales@roche.com "I am pleased to see Custom Biotech being recognized within the top five once again. Being part of the Roche organization allows us to provide expertise as well as state-of-the-art equipment and technologies from across all Roche business units to address our customer's needs." Our goal is to enable the healthcare industry by providing state of the art, customized solutions and services for development and manufacturing of diagnostic and therapeutic products." — Peter Schramm, VP SAFC St. Louis, MO www.safcglobal.com (800) 244-1173 Manufacturing locations: Arklow, Ireland; Buchs, Switzerland; Bangalore; Carlsbad; Jerusalem; Madison/Verona; St. Louis, U.S.A. Contact: Sobia Nayyar sobia.nayyar@sial.com DRUG LIFE CYCLE STAGES